Common Stock Reserved For Issuance

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Common Stock Reserved For Issuance

10. COMMON STOCK RESERVED FOR ISSUANCE

Common stock has been reserved for the following potential future issuances:

	As of March 31, 2019		As of December 31, 2018
Shares underlying outstanding stock options		538,702		405,683
Shares available for future stock option grants		289,981		423,000
Exchange of Vaccinex Products, LP units		1,202,566		1,202,566
Conversion of VX3 units		1,318,797		1,318,797
Total shares of common stock reserved		3,350,046		3,350,046